title: Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors.
abstract: Endometrial cancer is the most common gynecologic malignancy in the United States. However, its underlying molecular mechanisms are poorly understood; and few prognostic indicators have been identified. The protein kinase C (PKC) family has been shown to regulate pathways critical to malignant transformation; and in endometrial tumors, changes in PKC expression and activity have been linked to a more aggressive phenotype and poor prognosis. We have recently shown that PKC delta is a critical regulator of apoptosis and cell survival in endometrial cancer cells; however, PKC delta levels in endometrial tumors had not been determined. We used immunohistochemistry to examine PKC delta protein levels in normal endometrium and endometrioid carcinomas of increasing grade. Normal endometrium exhibited abundant nuclear and cytoplasmic staining of PKC delta confined to glandular epithelium. In endometrial tumors, decreased PKC delta expression, both in intensity and fraction of epithelial cells stained, was observed with increasing tumor grade, with PKC delta being preferentially lost from the nucleus. Consistent with these observations, endometrial cancer cell lines derived from poorly differentiated tumors exhibited reduced PKC delta levels relative to well-differentiated lines. Treatment of endometrial cancer cells with etoposide resulted in a translocation of PKC delta from cytoplasm to nucleus concomitant with induction of apoptosis. Decreased PKC delta expression, particularly in the nucleus, may compromise the ability of cells to undergo apoptosis, perhaps conferring resistance to chemotherapy. Our results indicate that loss of PKC delta is an indicator of endometrial malignancy and increasing grade of cancer. Thus, PKC delta may function as a tumor suppressor in endometrial cancer.
authors.affiliation: Department of Obstetrics and Gynecology, Program in Reproductive Sciences, University of Colorado Health Sciences Center, Aurora, CO 80045, USA.
authors.forename: Elaine M
authors.initials: EM
authors.lastname: Reno
authors.forename: James M
authors.initials: JM
authors.lastname: Haughian
authors.forename: Irina K
authors.initials: IK
authors.lastname: Dimitrova
authors.forename: Twila A
authors.initials: TA
authors.lastname: Jackson
authors.forename: Kenneth R
authors.initials: KR
authors.lastname: Shroyer
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Bradford
mesh_terms: D021581:Active Transport, Cell Nucleus; D000230:Adenocarcinoma / Q000378:metabolism*; D017209:Apoptosis; D002467:Cell Nucleus / Q000378:metabolism; D049109:Cell Proliferation; D016889:Endometrial Neoplasms / Q000378:metabolism*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D051745:Protein Kinase C-delta / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D051745:Protein Kinase C-delta